Multitarget fluorescence in situ hybridization diagnostic applications in solid and hematological tumors
F Zito Marino, M Brunelli, G Rossi… - Expert Review of …, 2021 - Taylor & Francis
… chromosome in chronic myelogenous leukemia followed by … ) of the control values are
used to evaluate a disomic pattern [Citation45]. … stage and during clinical remission [Citation95]. …
used to evaluate a disomic pattern [Citation45]. … stage and during clinical remission [Citation95]. …
Clinical potential of introducing next‐generation sequencing in patients at relapse of acute myeloid leukemia
J Flach, E Shumilov, G Wiedemann… - Hematological …, 2020 - Wiley Online Library
… , PCR techniques, and fluorescence in situ hybridization. RNA-… cells in day +30 remission
samples was associated with a … In summary, NGS has enlarged the options for monitoring of …
samples was associated with a … In summary, NGS has enlarged the options for monitoring of …
[HTML][HTML] Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis
AAB Salman, ARZ Zaidi, SY Altaf… - The American Journal …, 2020 - ncbi.nlm.nih.gov
… Fluorescence in situ hybridization (FISH) analysis showed … and molecular remission, she
presented with severe headache, nausea, … irradiation can effectively control CNS disease and …
presented with severe headache, nausea, … irradiation can effectively control CNS disease and …
CNS involvement in a patient with chronic myeloid leukemia
MA Healey, DJ Allendorf, U Borate… - Case Reports in …, 2021 - Wiley Online Library
… Patients require monitoring of complete blood count with … analysis or interphase fluorescence
in situ hybridization (FISH), … , cytogenetic, and molecular remissions, treatment failures as a …
in situ hybridization (FISH), … , cytogenetic, and molecular remissions, treatment failures as a …
Association between measurable residual disease in patients with intermediate-risk acute myeloid leukemia and first remission, treatment, and outcomes
S Yu, Z Fan, L Ma, Y Wang, F Huang… - JAMA Network …, 2021 - jamanetwork.com
… reverse banding techniques and fluorescence in situ hybridization. Molecular markers were
… Multiparameter flow cytometry was routinely used for MRD monitoring. The MRD level of 0.1…
… Multiparameter flow cytometry was routinely used for MRD monitoring. The MRD level of 0.1…
Current Status and Management of Chronic Myeloid Leukemia in the Gulf Region: Survey Results and Expert Opinion
… that consider fluorescence in situ hybridization (FISH) and … -up and monitoring across
different institutions and sectors. … such a close monitoring frequency, since losing remission is an …
different institutions and sectors. … such a close monitoring frequency, since losing remission is an …
… in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia
G Greiner, F Ratzinger, M Gurbisz… - Clinical Chemistry and …, 2020 - degruyter.com
… can be detected by fluorescence in situ hybridization (FISH) or … Likewise, treatment free
remission was not assessed within … monitoring of BCR-ABL in chronic myelogenous leukemia …
remission was not assessed within … monitoring of BCR-ABL in chronic myelogenous leukemia …
How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML)
… complete remission (CR1), a group where decisions about post-… In our practice, we
recommend MRD monitoring for all … Although cytogenetics and fluorescence in situ hybridisation (…
recommend MRD monitoring for all … Although cytogenetics and fluorescence in situ hybridisation (…
Minimal residual disease eradication by azacitidine maintenance in a patient with core-binding factor acute myeloid leukemia
OK Yucel, MS Alemdar, U Atas, L Undar - Chemotherapy, 2021 - karger.com
… remission was achieved at day 21 bone marrow evaluation, and CBFB-MYH11 was absent
both by cytogenetic analysis and fluorescence in situ hybridization, … MRD monitoring every 3 …
both by cytogenetic analysis and fluorescence in situ hybridization, … MRD monitoring every 3 …
Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes
… hematologic remission, allows for disease monitoring and is … features with subtypes of acute
myeloid leukemia (AML), … del(5q) using fluorescence in situ hybridization of sorted CD34+, …
myeloid leukemia (AML), … del(5q) using fluorescence in situ hybridization of sorted CD34+, …